ALZINOVA AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.21 SEK | +3.42% |
|
+2.54% | -60.13% |
| 06-18 | Alzinova AB Announces All Patients Have Been Recruited in the High-Dose Part of Alzinova's Phase 1B Study | CI |
| 06-10 | Alzinova AB Announces New External Safety Review for Phase 1b Study | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 5.08M | - | - | - | |||
| 45.51B | - | |||||
| 38.52B | ||||||
| 38.13B | ||||||
| 30.74B | - | |||||
| 26.03B |
- Stock Market
- Equities
- ALZ Stock
- Charts Alzinova AB
- Sector Chart
